LINGO1
protein-codingleucine rich repeat and Ig domain containing 1, the group of I-set domain containing
Gene summary
Predicted to enable epidermal growth factor receptor binding activity and signaling receptor activity. Predicted to be involved in neuron development. Predicted to act upstream of or within negative regulation of oligodendrocyte differentiation; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; and neuron development. Located in plasma membrane. Implicated in autosomal recessive intellectual developmental disorder 64 and glaucoma. [provided by Alliance of Genome Resources, Jun 2026]
- LRRN6A
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~207.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0020846
Submitter: G2P
Inheritance Pattern: Unknown
Disease ID:MONDO:0020846
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0020846
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0020846
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LINGO1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_032808.7. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 31 | 3 | 34 | |||
| missense | 2 | 1 | 88 | 2 | 93 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 2 | 1 | 88 | 33 | 3 | 127 |
Highest pathogenic variant AF is 0.000024165007
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_116197.4 | 2 | MANE Select | |
| Ensembl | ENSP00000347451.6 | 2 | MANE Select | |
| RefSeq | NP_001288115.1 | 1 | Standard | |
| RefSeq | NP_001288116.1 | 1 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| lingo1b | Danio rerio | Structure: neuron Quality: increased thickness abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Brain-Derived Neurotrophic Factor (BDNF) signaling pathway
- Signal Transduction
- BDNF
- Death Receptor Signalling
- Axonal growth inhibition (RHOA activation)
Biological Process
- negative regulation of axonogenesis
Molecular Function
- epidermal growth factor receptor binding
- protein binding
Cellular Component
- extracellular space
- plasma membrane
- integral component of membrane
- extracellular matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000355300
- Coding exons
- 2
- Length
- 207874
- Individuals with no LoFs
- 124118
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 124119
- p
- 0.00000403
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.80 | 242 | 400 | 0.606 | 0.0000291 | 3945 |
| Missense (PolyPhen) | 50 | 134.77 | 0.37101 | 1410 | ||
| Synonymous | -0.717 | 210 | 197 | 1.06 | 0.0000158 | 1311 |
| Loss of Function | 3.62 | 0 | 15.3 | 0.00 | 8.32e-7 | 164 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00017 | 0.00017 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Functional component of the Nogo receptor signaling complex (RTN4R/NGFR) in RhoA activation responsible for some inhibition of axonal regeneration by myelin-associated factors (PubMed:14966521, PubMed:15694321). Is also an important negative regulator of oligodentrocyte differentiation and axonal myelination (PubMed:15895088). Acts in conjunction with RTN4 and RTN4R in regulating neuronal precursor cell motility during cortical development (By similarity). {ECO:0000250|UniProtKB:Q9D1T0, ECO:0000269|PubMed:14966521, ECO:0000269|PubMed:15694321, ECO:0000269|PubMed:15895088}.;
Recessive Scores
- pRec
- 0.170
Intolerance Scores
- RVIS EVS
- -1.42
- RVIS percentile EVS
- 4.1
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.856
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |